Clinical Trial

GMALL Registry and Collection of Biomaterial: Prospective Data Collection Regarding Diagnosis, Treatment and Outcome of Adult Acute Lymphoblastic Leukemia (ALL) Patients and Related Diseases Associated With a Prospective Collection of Biomaterial

Study acronym: GMALLregistry
Recruiting
View on ClinicalTrials.gov →
Summary
The GMALL registry serves the purpose of ALL research and quality assurance. The Registry collects data about diagnostics, treatment and outcome of Adult ALL Patients in the clinical routine, whether or not the patient is treated within a clinical trial.
Protocol Amendment History 1 change
notable Trial sites reduced: 152 -> 147 locations 2026-08-06
Trial Details
NCT Number NCT02872987
Lead Sponsor Goethe University
Conditions Acute Lymphoblastic Leukemia, Leukemia, Non-Hodgkin's Lymphoma
Enrollment 10,000 participants
Start Date 2009-02
Primary Completion 2030-12 (estimated)
Study Completion 2035-12 (estimated)
Updated on ClinicalTrials.gov 2026-08-05